Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates.

Abstract

A series of benzothiazole and benzoxazole linked pyrrolobenzodiazepine conjugates attached through different alkane or alkylamide spacers was prepared. Their anticancer activity, DNA thermal denaturation studies, restriction endonuclease digestion assay and flow cytometric analysis in human melanoma cell line (A375) were investigated. One of the compounds of the series 17d showed significant anticancer activity with promising DNA-binding ability and apoptosis caused G0/G1 phase arrest at sub-micromolar concentrations. To ascertain the binding mode and understand the structural requirement of DNA binding interaction, molecular docking studies using GOLD program and more rigorous 2 ns molecular dynamic simulations using Molecular Mechanics-Poisson-Boltzman Surface Area (MM-PBSA) approach including the explicit solvent were carried out. Further, the compound 17d was evaluated for in vivo efficacy studies in human colon cancer HT29 xenograft mice.

DOI: 10.1016/j.bmc.2010.05.007
0204060201220132014201520162017
Citations per Year

85 Citations

Semantic Scholar estimates that this publication has 85 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kamal2010SynthesisDA, title={Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates.}, author={Ahmed Tashrif Kamal and K. Srinivasa Reddy and Mohammed Naseer Ahmed Khan and Rajesh V C R N C Shetti and Manjula Ramaiah and Sreerangam N. C. V. L. Pushpavalli and Chatla Srinivas and Manika Pal-Bhadra and Mukesh Chourasia and G. Narahari Sastry and Aarti Shashikant Juvekar and Surekha Mahesh Zingde and Madan S Barkume}, journal={Bioorganic & medicinal chemistry}, year={2010}, volume={18 13}, pages={4747-61} }